Peginterferon alpha1b - Shanghai Institute of Biological Products
Alternative Names: PEGIFNα1bLatest Information Update: 03 Feb 2023
At a glance
- Originator Shanghai Institute of Biological Products
- Class Antivirals; Interferons; Polyethylene glycols
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Herpes zoster
Most Recent Events
- 07 Jul 2020 Phase-I clinical trials in Herpes zoster (In adults, In volunteers) in China (SC) (NCT05639803)